跳至主要内容
临床试验/PER-041-04
PER-041-04已完成未知

CONTROLLED STUDY OF FERROUS POLYMOTHERATE VS. FERROUS SULPHATE IN THE TREATMENT OF FERROPENIC ANEMIA IN CHILDREN FROM 6 MONTHS TO TWO YEARS.

ABL PHARMA PERU,0 个研究点目标入组 0 人开始时间: 2004年7月21日最近更新:

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 0(—)

入选标准

  • 1. Acceptance by the parents or legal guardians of the child documented with signing the corresponding informed consent form.
  • 2. Have an age between 6 months and 2 years
  • 3. Hemoglobin> 8 and <11 g / dl and / or decreased serum Ferritin.
  • 4. Have the possibility of attending the consultation according to the schedule of study.
  • 5. Be included between the percentiles 10-90, age-statural for age and
  • sex according to the tables of the NCHS.

排除标准

  • 1. History of intolerance to iron salts
  • 2. History of chronic anemia resistant to treatment
  • 3. Acute pathologies (e.g., acute infections) or chronic diseases (e.g.
  • intestinal absorption) that can modify the blood values
  • 4. Intestinal parasitic diseases detected by simple parasitological examination at the beginning of the study.
  • 5. Need to use drugs that can modify the hematological values (e.g., prolonged use of AMEs, steroids in the last 3 months, cytostatics)
  • 6. History of blood dyscracies
  • 7. History of liver or kidney pathology

研究者

发起方
ABL PHARMA PERU,

相似试验